Clinical trial
ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial
NCT02326350 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial
- Lead sponsor
- Belfast Health and Social Care Trust
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 6, 2015
- Completion date
- November 23, 2018
- Enrollment
- 49 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory distress syndrome